Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
13,30 € ↓ -0,40 (-2,92%)
2026-06-02
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionHeadlands Technologies LLC
Latest Disclosed Ownership57,635 shares
Latest Disclosed Value $ 542,922
Headlands Technologies LLC reports 14.91% increase in ownership of IL3 / Integra LifeSciences Holdings Corporation

On May 13, 2026 - Headlands Technologies LLC filed a 13F-HR form disclosing ownership of 57,635 shares of Integra LifeSciences Holdings Corporation (DE:IL3) valued at $455,316 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 50,158 shares of Integra LifeSciences Holdings Corporation. This represents a change in shares of 14.91% during the quarter. The current value of the position is $766,546 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 57,635 7,477 14.91 543 -12.86 0.0618
2026-02-13 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 50,158 17,463 53.41 623 32.91 0.0520
2025-11-12 2025-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 32,695 18,742 134.32 469 173.68 0.0374
2025-08-14 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 13,953 -764 -5.19 171 -47.06 0.0205
2025-05-09 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 14,717 2,783 23.32 324 19.63 0.0369
2025-02-12 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 11,934 11,934 271 0.0272
2024-11-12 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -26,592 -100.00 0 -100.00
2024-08-07 2024-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 26,592 21,828 458.19 775 360.71 0.0822
2024-05-07 2024-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,764 1,677 54.32 169 25.37 0.0406
2024-02-02 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,087 -9,862 -76.16 134 -72.87 0.0401
2023-11-09 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 12,949 6,163 90.82 495 77.06 0.2431
2023-08-03 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 6,786 6,786 279 0.0893
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.